Healthcare Integrated Technologies Inc
For the period ended Apr 30, 2024. Filed Jun 20, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2024 · Filed Jun 20, 2024
SSGCStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Interim Consolidated Statements of Changes in Stockholders’ Deficit (Unaudited)
INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
| Common Stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Deficit | |
| Balances at July 31, 2023 | 68,016,167 | $68,016 | $14,878,282 | $(15,612,166) | $(665,868) |
| Net loss | (383,663) | (383,663) | |||
| Shares issued for cash | 1,000,000 | 1,000 | 99,000 | 100,000 | |
| Shares issued for services | 1,100,000 | 1,100 | (1,100) | - | |
| Shares issued for loan modification | 326,813 | 327 | (327) | - | |
| Stock-based compensation | 282,031 | 282 | 25,553 | 25,835 | |
| Activity for the six months ended January 31, 2024 | 2,708,844 | 2,709 | 123,126 | (383,663) | (257,828) |
| Net loss | (215,218) | (215,218) | |||
| Issuance of shares for cash | 2,250,000 | 2,250 | 222,750 | 225,000 | |
| Issuance of shares for loan modification | 243,531 | 244 | (244) | - | |
| Stock-based compensation | - | - | 78,362 | 78,362 | |
| Activity for the three months ended April 30, 2024 | 2,493,531 | 2,494 | 300,867 | (215,218) | 88,144 |
| Balances at April 30, 2024 | 73,218,542 | $73,219 | $15,302,276 | $(16,211,047) | $(835,552) |
| Common Stock · Additional Paid-In · Accumulated · Total Stockholders’ | |||||
|---|---|---|---|---|---|
| Shares | Amount | Capital | Deficit | Deficit | |
| Balances at July 31, 2022 | 42,304,673 | $42,305 | $11,839,645 | $(14,309,708) | $(2,427,758) |
| Net loss | (860,991) | (860,991) | |||
| Shares issued for services | 250,000 | 250 | 13,750 | ||
| Shares issued for the conversion of debt and related accrued interest | 120,726 | 121 | 60,242 | 60,363 | |
| Stock-based compensation | 154,662 | 154 | 189,323 | 189,477 | |
| Activity for the six months ended January 31, 2023 | 525,388 | 525 | 263,065 | (860,991) | (597,401) |
| Net loss | (246,530) | (246,530) | |||
| Shares issued for cash | 3,000,000 | 3,000 | 297,000 | 300,000 | |
| Shares issued for services | 200,000 | 200 | 14,800 | 15,000 | |
| Shares issued for the conversion of debt and related accrued interest | 254,446 | 254 | 126,969 | 127,223 | |
| Shares issued for note amendment fees | 1,000,000 | 1,000 | 99,000 | 100,000 | |
| Stock-based compensation | 197,877 | 198 | 97,570 | 97,768 | |
| Activity for the three months ended April 30, 2023 | 4,652,323 | 4,652 | 635,339 | (246,530) | 393,461 |
| Balances at April 30, 2023 | 47,482,384 | $47,482 | $12,738,049 | $(15,417,229) | $(2,631,698) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.